Download presentation
Presentation is loading. Please wait.
Published byCaroline Green Modified over 6 years ago
1
Mammalian Cell Expression Profacgen
2
Mammalian cell expression systems are the best choice for the production of eukaryotic proteins, especially when correct folding and post-translational modification (glycosylation, phosphorylation, etc.) is required. They produce eukaryotic recombinant proteins in the most natural state, with native tertiary structure, physiochemical characteristics, and bioactivities.
3
They have been successfully applied in the biopharmaceutical production of cytokines, monoclonal antibodies, growth factors and so on. The most widely-used mammalian cell lines are HEK293 and CHO cells.
4
Features Protein production with accurate post-translational modification Bioactive protein production Transient and stable expression Large-scale protein production
5
HEK293 expression Human Embryonal Kidney 293 (HEK293) cells have been extensively used for the transient expression of recombinant proteins. Their ease of culture and highly efficient transfection rate make them especially suitable for customized protein production for research use.
6
CHO expression Chinese Hamster Ovary (CHO) cells, which have been successfully used for the manufacture of FDA-approved therapeutic proteins and antibodies, are prominent in stable expression. Stably transfected CHO cell line is the most suitable mammalian host for high-yield production of recombinant proteins. They are adaptable to diverse culture conditions. Protein purification from CHO culture is also relatively easy because of their secretory feature.
7
Profacgen provides you with an ultimate solution of mammalian protein production. Our service can be tailored with your specialized requirements. Our expertise guarantees high protein quality, short turnaround time, and the best price in the market!
8
Thanks for watching! Contact Profacgen Address: 45-1 Ramsey Road Shirley, NY 11967, USA Website: https://www.profacgen.com
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.